Canada’s First Joint Oncology-Allergy Clinic: Successful Desensitization to Trastuzumab Following Severe Anaphylactic Reaction in Which Epinephrine Was Inappropriately Withheld

Background: Recognition of anaphylaxis and differentiation from other infusion reactions in an oncology setting is imperative; epinephrine is the recommended treatment for anaphylaxis and should be administered immediately to patients in whom anaphylaxis is suspected. Trastuzumab has a potentially t...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Madeline, Geirnaert, Marc, Anderson, Brady, McKibbin, Lundy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046925/
https://www.ncbi.nlm.nih.gov/pubmed/36975431
http://dx.doi.org/10.3390/curroncol30030218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046925/
https://www.ncbi.nlm.nih.gov/pubmed/36975431
http://dx.doi.org/10.3390/curroncol30030218

Ejemplares similares